Stay updated on Nivolumab Plus Ipilimumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in Melanoma Clinical Trial page.

Latest updates to the Nivolumab Plus Ipilimumab in Melanoma Clinical Trial page
- Check6 days agoChange DetectedAdded related topics: Melanoma and MedlinePlus Genetics; updated the page revision from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedAdded Revision: v3.4.2; removed the funding-status notice, older Revision: v3.4.1 reference, and melanoma-related topic tags.SummaryDifference0.3%

- Check41 days agoChange DetectedA site-wide funding-status notice banner was added to the page, directing users to cc.nih.gov and opm.gov for updates, and the version tag shows Revision: v3.4.1 replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check48 days agoChange DetectedUI changes include adding a glossary toggle and updating metadata labels: Last Update Submitted that Met QC Criteria and Revision: v3.4.0, while older labels such as Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4 were removed or adjusted. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check55 days agoChange DetectedAdded Melanoma as a condition and linked MedlinePlus Genetics related topics. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page now shows Revision: v3.3.4, replacing the previous v3.3.3, which is a minor update with no visible impact on study content or functionality — To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Nivolumab Plus Ipilimumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in Melanoma Clinical Trial page.